Search Count: 369
 |
Organism: Mus musculus, Rattus norvegicus, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2026-02-04 Classification: ANTITUMOR PROTEIN/Immune System |
 |
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Resolution:3.02 Å Release Date: 2026-02-04 Classification: ANTITUMOR PROTEIN/Immune System |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Resolution:3.44 Å Release Date: 2026-02-04 Classification: ANTITUMOR PROTEIN |
 |
Organism: Mus sp.
Method: ELECTRON MICROSCOPY Release Date: 2026-01-28 Classification: ANTITUMOR PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2026-01-21 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Organism: Oryctolagus cuniculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2025-11-12 Classification: ANTITUMOR PROTEIN Ligands: GOL |
 |
Organism: Saccharomyces cerevisiae (strain atcc 204508 / s288c)
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2025-10-22 Classification: ANTITUMOR PROTEIN Ligands: ZN |
 |
Her3 Receptor In Complex With The Fab Fragment Of Tk-Hu A3 Monoclonal Antibody
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2025-10-15 Classification: ANTITUMOR PROTEIN Ligands: NAG, SCN |
 |
Crystal Structure Of Bacillus Subtilis 168 L-Asparaginase Ii With Antileukemic Activity
Organism: Bacillus subtilis subsp. subtilis str. 168
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2025-10-08 Classification: ANTITUMOR PROTEIN |
 |
Organism: Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2025-10-01 Classification: ANTITUMOR PROTEIN |
 |
Structural Insights Into The Tumor Suppressor Zmynd11 Reveal Diverse Recognition Mechanisms
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2025-08-13 Classification: ANTITUMOR PROTEIN Ligands: ZN |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-16 Classification: ANTITUMOR PROTEIN Ligands: A1EG3 |
 |
Crystal Structure Of Hdm2 In Complex With A Peptidic Ligand Containing A Di-Urea Insert.
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-07-02 Classification: ANTITUMOR PROTEIN Ligands: PO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-06-11 Classification: ANTITUMOR PROTEIN/INHIBITOR Ligands: ZN, GOL, A1LUZ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-06-11 Classification: ANTITUMOR PROTEIN/INHIBITOR Ligands: ZN, A1LU0 |
 |
Local Refinement Structure Of Segfr And 528 Fv (From Hl-Type Bispecific Diabody Ex3) Complex
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Resolution:3.21 Å Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Closed Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Middle Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Poly-Alanine Model For Hl-Type Bispecific Diabody Ex3 Composed Of 528 And Okt3 Fvs In Ternary Complex With Segfr And Cd3Gamma-Epsilon (Open Conformation)
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM |
 |
Local Refinement Structure Of Segfr And 528 Fv (From Lh-Type Bispecific Diabody Ex3) Complex
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Resolution:2.93 Å Release Date: 2025-05-28 Classification: ANTITUMOR PROTEIN/IMMUNE SYSTEM Ligands: NAG |